Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Abstract LB336: pH-sensitive polymeric micelles loading IL-12 profoundly inflame the tumor microenvironment to eradicate cold tumors

Horacio Cabral, Pengwen Chen, Koji Nagaoka, Takuya Miyazaki, Kazunori Kataoka, Kazuhiro Kakimi

Cancer Res (2023) 83 (8_Supplement): LB336.

https://doi.org/10.1158/1538-7445.AM2023-LB336

Published: 14 April 2023

View article titled, Abstract LB336: pH-sensitive polymeric micelles loading IL-12 profoundly inflame the tumor microenvironment to eradicate cold tumors

Journal Articles

Abstract 1571: Neoantigen vaccine plus CD38 blockade suppress the proliferation of murine cold lung cancer LLC1

Changbo Sun, Koji Nagaoka, Akihiro Hosoi, Yukari Kobayashi, Jun Nakajima, Kazuhiro Kakimi

Cancer Res (2021) 81 (13_Supplement): 1571.

https://doi.org/10.1158/1538-7445.AM2021-1571

Published: 01 July 2021

View article titled, Abstract 1571: Neoantigen vaccine plus CD38 blockade suppress the proliferation of murine cold lung cancer LLC1

Journal Articles

Abstract 1069: Autologous γδ T cell therapy for treatment-refractory non-small-cell lung cancer: An open-label, single-arm, multicenter, phase II study

Kazuhiro Kakimi, Hirokazu Matsushita, Takamichi Izumi, Keita Masuzawa, Takahiro Karasaki, Shinnosuke Ikemura, Kentaro Kitano, Ichiro Kawata, Tadashi Manabe, Tomohiro Takehara, Toshiaki Ebisudani, Kazuiro Nagayama, Hiroyuki Yasuda, Masaaki Sato, Kenzo Soejima, Jun Nakajima

Cancer Res (2020) 80 (16_Supplement): 1069.

https://doi.org/10.1158/1538-7445.AM2020-1069

Published: 15 August 2020

View article titled, Abstract 1069: Autologous γδ T cell therapy for treatment-refractory non-small-cell lung cancer: An open-label, single-arm, multicenter, phase II study

Journal Articles

Abstract 6610: To identify neoantigens relevant to anti-tumor activity is challenging even with NGS-based prediction combined with MHC ligandome profiling

Koji Nagaoka, Takayuki Kanaseki, Changbo Sun, Akihiro Hosoi, Serina Tokita, Kazuhiro Maejima, Masashi Fujita, Hidewaki Nakagawa, Toshihiko Torigoe, Kazuhiro Kakimi

Cancer Res (2020) 80 (16_Supplement): 6610.

https://doi.org/10.1158/1538-7445.AM2020-6610

Published: 15 August 2020

View article titled, Abstract 6610: To identify neoantigens relevant to anti-tumor activity is challenging even with NGS-based prediction combined with MHC ligandome profiling

Journal Articles

Abstract 1550: Single-cell RNA-Seq identified an immunosuppressive IL-17 producing tumor-infiltrating T cells in murine gastric tumor model

Masataka Shirai, Koji Nagaoka, Kiyomi Taniguchi, Changbo Sun, Akihiro Hosoi, Kazuhiro Kakimi

Cancer Res (2020) 80 (16_Supplement): 1550.

https://doi.org/10.1158/1538-7445.AM2020-1550

Published: 15 August 2020

View article titled, Abstract 1550: Single-cell RNA-Seq identified an immunosuppressive IL-17 producing tumor-infiltrating T cells in murine gastric tumor model

Journal Articles

Abstract 2050: Novel immunological classification of gastric cancer by integrative analysis

Yasuyoshi Sato, Ikuo Wada, Akihiro Hosoi, Yukari Kobayashi, Koji Nagaoka, Takahiro Karasaki, Hirokazu Matsushita, Koichi Yagi, Hiroharu Yamashita, Shunji Takahashi, Yasuyuki Seto, Kazuhiro Kakimi

Cancer Res (2020) 80 (16_Supplement): 2050.

https://doi.org/10.1158/1538-7445.AM2020-2050

Published: 15 August 2020

View article titled, Abstract 2050: Novel immunological classification of gastric cancer by integrative analysis

Journal Articles

Abstract 1721: Diversity evenness of TCR repertoire in the tumor and periphery reflects antitumor activity and immune-related adverse events, respectively

Akihiro Hosoi, Hirokazu Matsushita, Kazuyoshi Takeda, Ryuji Suzuki, Kazuhiro Kakimi

Cancer Res (2018) 78 (13_Supplement): 1721.

https://doi.org/10.1158/1538-7445.AM2018-1721

Published: 01 July 2018

View article titled, Abstract 1721: Diversity evenness of TCR repertoire in the tumor and periphery reflects antitumor activity and immune-related adverse events, respectively

Journal Articles

Abstract 3663: An anti-CD4 depleting antibody reverses regulatory T-cell-induced suppression of dendritic cells while preventing nonspecific CD4⁺ T cell responses in tumor-bearing mice

Satoshi Ueha, Haru Ogiwara, Shoji Yokochi, Yoshiro Ishiwata, Francis Shand, Shohei Hori, Kazuhiro Kakimi, Satoru Ito, Kouji Matsushima

Cancer Res (2017) 77 (13_Supplement): 3663.

https://doi.org/10.1158/1538-7445.AM2017-3663

Published: 01 July 2017

View article titled, Abstract 3663: An anti-CD4 depleting antibody reverses regulatory T-cell-induced suppression of dendritic cells while preventing nonspecific CD4<sup>+</sup> T cell responses in tumor-bearing mice

Journal Articles

Abstract 1706: Neoantigen frequency as an independent prognostic factor in patients with clear cell ovarian carcinoma (CCOC)

Hirokazu Matsushita, Kosei Hasegawa, Katsutoshi Oda, Shogo Yamamoto, Akira Nishijima, Yuichi Imai, Kayo Asada, Yuji Ikeda, Takahiro Karasaki, Keiichi Fujiwara, Hiroyuki Aburatani, Kazuhiro Kakimi

Cancer Res (2017) 77 (13_Supplement): 1706.

https://doi.org/10.1158/1538-7445.AM2017-1706

Published: 01 July 2017

View article titled, Abstract 1706: Neoantigen frequency as an independent prognostic factor in patients with clear cell ovarian carcinoma (CCOC)

Journal Articles

Abstract 4571: Advantage of dendritic cells for the therapeutic cancer vaccine

Koji Nagaoka, Akihiro Hosoi, Tamaki Iino, Hirokazu Matsushita, Kazuhiro Kakimi

Cancer Res (2017) 77 (13_Supplement): 4571.

https://doi.org/10.1158/1538-7445.AM2017-4571

Published: 01 July 2017

View article titled, Abstract 4571: Advantage of dendritic cells for the therapeutic cancer vaccine

Journal Articles

Vaccination with Antigen-Transfected, NKT Cell Ligand–Loaded, Human Cells Elicits Robust In Situ Immune Responses by Dendritic Cells

Cancer Res (2013) 73 (1): 62–73.

https://doi.org/10.1158/0008-5472.CAN-12-0759

Published: 02 January 2013

View article titled, Vaccination with Antigen-Transfected, NKT Cell Ligand–Loaded, Human Cells Elicits Robust <em>In Situ</em> Immune Responses by Dendritic Cells

Includes: Supplementary data

Journal Articles

Abstract 3520: Targeting spatiotemporal expression of CD137 on tumor-specific cytotoxic T lymphocytes as a novel strategy for agonistic antibody therapy

Kazuhiro Kakimi, Akihiro Hosoi, Shuichi Noji, Hirokazu Matsushita, Kazuyoshi Takeda

Cancer Res (2012) 72 (8_Supplement): 3520.

https://doi.org/10.1158/1538-7445.AM2012-3520

Published: 15 April 2012

View article titled, Abstract 3520: Targeting spatiotemporal expression of CD137 on tumor-specific cytotoxic T lymphocytes as a novel strategy for agonistic antibody therapy

Journal Articles

Abstract 1926: Adoptive γδ T cell transfer therapy for non-small cell lung cancer

Kazuhiro Kakimi, Tomohiro Murakawa, Takeshi Fukami, Shigenori Goto, Toru Kaneko, Yukihiro Yoshida, Shin-ichi Takamoto, Jun Nakajima

Cancer Res (2010) 70 (8_Supplement): 1926.

https://doi.org/10.1158/1538-7445.AM10-1926

Published: 15 April 2010

View article titled, Abstract 1926: Adoptive γδ T cell transfer therapy for non-small cell lung cancer

Journal Articles

Memory Th1 Cells Augment Tumor-Specific CTL following Transcutaneous Peptide Immunization

Akihiro Hosoi, Yayoi Takeda, Yoshihiro Furuichi, Makoto Kurachi, Kiminori Kimura, Ryuji Maekawa, Kiyoshi Takatsu, Kazuhiro Kakimi

Cancer Res (2008) 68 (10): 3941–3949.

https://doi.org/10.1158/0008-5472.CAN-08-0032

Published: 15 May 2008

View article titled, Memory Th1 Cells Augment Tumor-Specific CTL following Transcutaneous Peptide Immunization

Journal Articles

Efficient expansion and activation of tumor-specific CTLs by transcutaneous CTL and Th1 epitope peptide immunization with TLR7 ligand

Kazuhiro Kakimi, Akihiro Hosoi, Kiminori Kimura, Ryuji Maekawa, Kiyoshi Takatsu

Cancer Res (2008) 68 (9_Supplement): 2082.

Published: 01 May 2008

View article titled, Efficient expansion and activation of tumor-specific CTLs by transcutaneous CTL and Th1 epitope peptide immunization with TLR7 ligand

NARROW

Abstract LB336: pH-sensitive polymeric micelles loading IL-12 profoundly inflame the tumor microenvironment to eradicate cold tumors

Abstract 1571: Neoantigen vaccine plus CD38 blockade suppress the proliferation of murine cold lung cancer LLC1

Abstract 1069: Autologous γδ T cell therapy for treatment-refractory non-small-cell lung cancer: An open-label, single-arm, multicenter, phase II study

Abstract 6610: To identify neoantigens relevant to anti-tumor activity is challenging even with NGS-based prediction combined with MHC ligandome profiling

Abstract 1550: Single-cell RNA-Seq identified an immunosuppressive IL-17 producing tumor-infiltrating T cells in murine gastric tumor model

Abstract 2050: Novel immunological classification of gastric cancer by integrative analysis

Abstract 1721: Diversity evenness of TCR repertoire in the tumor and periphery reflects antitumor activity and immune-related adverse events, respectively

Abstract 3663: An anti-CD4 depleting antibody reverses regulatory T-cell-induced suppression of dendritic cells while preventing nonspecific CD4⁺ T cell responses in tumor-bearing mice

Abstract 1706: Neoantigen frequency as an independent prognostic factor in patients with clear cell ovarian carcinoma (CCOC)

Abstract 4571: Advantage of dendritic cells for the therapeutic cancer vaccine

Vaccination with Antigen-Transfected, NKT Cell Ligand–Loaded, Human Cells Elicits Robust In Situ Immune Responses by Dendritic Cells

Abstract 3520: Targeting spatiotemporal expression of CD137 on tumor-specific cytotoxic T lymphocytes as a novel strategy for agonistic antibody therapy

Abstract 1926: Adoptive γδ T cell transfer therapy for non-small cell lung cancer

Memory Th1 Cells Augment Tumor-Specific CTL following Transcutaneous Peptide Immunization

Efficient expansion and activation of tumor-specific CTLs by transcutaneous CTL and Th1 epitope peptide immunization with TLR7 ligand

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only